# Vigamox Treatment for Ocular Graft-Versus-Host Disease

> **NCT04204122** · PHASE2 · WITHDRAWN · sponsor: **Washington University School of Medicine**

## Conditions studied

- Ocular Graft-versus-host Disease

## Interventions

- **DRUG:** Vigamox
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04204122
- **Lead sponsor:** Washington University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2020-06-15
- **Primary completion:** 2025-03-31
- **Final completion:** 2025-03-31
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Investigator decided to close study
- **Last updated:** 2023-08-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04204122

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04204122, "Vigamox Treatment for Ocular Graft-Versus-Host Disease". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT04204122. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*